Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® Compared to SYMBICORT® TURBOHALER®

- Asthma
- Completed

Study Title: Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAXֲ® as Compared to SYMBICORTֲ® TURBOHALERֲ® as Treatment for Adult Patients With Asthma

Teva Identifier: BFS-AS-40035 | 2013-004630-14

ClinicalTrials.gov Identifier: NCT02062463

Study Status: Completed

Trial Condition(s): Asthma

Interventions: Drug: Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX | Drug: SYMBICORT TURBOHALER budesonide and formoterol fumarate

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Adult, Older Adult

Age Range: 18 Years to 75 Years

Trial Duration: 06/01/2014 - 04/01/2015

Phase: Phase 4

Study Type

Interventional